These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23924315)

  • 21. Human bone marrow stromal cells: In vitro expansion and differentiation for bone engineering.
    Ciapetti G; Ambrosio L; Marletta G; Baldini N; Giunti A
    Biomaterials; 2006 Dec; 27(36):6150-60. PubMed ID: 16965811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of the biological characteristics of mesenchymal stem cells from bone marrow and peripheral blood of rats.
    Fu WL; Zhang JY; Fu X; Duan XN; Leung KK; Jia ZQ; Wang WP; Zhou CY; Yu JK
    Tissue Eng Part A; 2012 Sep; 18(17-18):1793-803. PubMed ID: 22721583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of the biological properties and gene expression profiles of murine bone marrow stromal cells.
    Lei J; Hui D; Huang W; Liao Y; Yang L; Liu L; Zhang Q; Qi G; Song W; Zhang Y; Xiang AP; Zhou Q
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2431-43. PubMed ID: 23911306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro differentiation and biocompatibility of mesenchymal stem cells on a novel platelet releasate-containing injectable composite.
    McCanless JD; Jennings LK; Cole JA; Bumgardner JD; Haggard WO
    J Biomed Mater Res A; 2012 Jan; 100(1):220-9. PubMed ID: 22042623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy.
    Reinders ME; Roemeling-van Rhijn M; Khairoun M; Lievers E; de Vries DK; Schaapherder AF; Wong SW; Zwaginga JJ; Duijs JM; van Zonneveld AJ; Hoogduijn MJ; Fibbe WE; de Fijter JW; van Kooten C; Rabelink TJ; Roelofs H
    Cytotherapy; 2013 Jun; 15(6):663-72. PubMed ID: 23419679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
    Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
    Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and characterization of mesenchymal stem cell-like cells from healthy and inflamed gingival tissue: potential use for clinical therapy.
    Ge S; Mrozik KM; Menicanin D; Gronthos S; Bartold PM
    Regen Med; 2012 Nov; 7(6):819-32. PubMed ID: 23164082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and myogenic differentiation of mesenchymal stem cells for urologic tissue engineering.
    Wu R; Liu G; Bharadwaj S; Zhang Y
    Methods Mol Biol; 2013; 1001():65-80. PubMed ID: 23494421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of equine mesenchymal stem cells derived from amnion and bone marrow: in vitro proliferative and multilineage potential assessment.
    Lange-Consiglio A; Corradetti B; Meucci A; Perego R; Bizzaro D; Cremonesi F
    Equine Vet J; 2013 Nov; 45(6):737-44. PubMed ID: 23527626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.
    Lu LL; Liu YJ; Yang SG; Zhao QJ; Wang X; Gong W; Han ZB; Xu ZS; Lu YX; Liu D; Chen ZZ; Han ZC
    Haematologica; 2006 Aug; 91(8):1017-26. PubMed ID: 16870554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guided bone regeneration in pig calvarial bone defects using autologous mesenchymal stem/progenitor cells - a comparison of different tissue sources.
    Stockmann P; Park J; von Wilmowsky C; Nkenke E; Felszeghy E; Dehner JF; Schmitt C; Tudor C; Schlegel KA
    J Craniomaxillofac Surg; 2012 Jun; 40(4):310-20. PubMed ID: 21723141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consistent osteoblastic differentiation of human mesenchymal stem cells with bone morphogenetic protein 4 and low serum.
    Cordonnier T; Langonné A; Sohier J; Layrolle P; Rosset P; Sensébé L; Deschaseaux F
    Tissue Eng Part C Methods; 2011 Mar; 17(3):249-59. PubMed ID: 20822481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The influence of freezing and storage on the characteristics and functions of human mesenchymal stromal cells isolated for clinical use.
    Haack-Sorensen M; Bindslev L; Mortensen S; Friis T; Kastrup J
    Cytotherapy; 2007; 9(4):328-37. PubMed ID: 17573608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of platelet-rich plasma and hydrostatic pressure regarding cell differentiation in nucleus pulposus tissue engineering.
    Mietsch A; Neidlinger-Wilke C; Schrezenmeier H; Mauer UM; Friemert B; Wilke HJ; Ignatius A
    J Tissue Eng Regen Med; 2013 Mar; 7(3):244-52. PubMed ID: 22162329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Autologous Platelet-Rich Plasma on Bone Regeneration by Autologous Mesenchymal Stem Cells Loaded onto Allogeneic Cancellous Bone Granules.
    Joo MW; Chung SJ; Shin SH; Chung YG
    Cells Tissues Organs; 2017; 203(6):327-338. PubMed ID: 28118635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The sensitivity of mesenchymal stromal cell subpopulations with different times of adhesion property manifestation and derived from hemopoietic organs to growth factors EGF, bFGF, and PDGF].
    Molchanova EA; Bueverova EI; Starostin VI; Domaratskaia EI
    Izv Akad Nauk Ser Biol; 2011; (2):133-44. PubMed ID: 21506387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quercitrin for periodontal regeneration: effects on human gingival fibroblasts and mesenchymal stem cells.
    Gómez-Florit M; Monjo M; Ramis JM
    Sci Rep; 2015 Nov; 5():16593. PubMed ID: 26558438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis.
    Uchiyama T; Kawabata H; Miura Y; Yoshioka S; Iwasa M; Yao H; Sakamoto S; Fujimoto M; Haga H; Kadowaki N; Maekawa T; Takaori-Kondo A
    Cancer Med; 2015 Oct; 4(10):1558-72. PubMed ID: 26276681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ectopic expression of CDX4 in human mesenchymal stem cells does not affect HOX gene expression or induce hematopoietic reprogramming.
    Szöke K; Beckstrøm KJ; Brinchmann JE
    Stem Cell Res; 2012 Sep; 9(2):135-42. PubMed ID: 22721648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The systemic influence of platelet-derived growth factors on bone marrow mesenchymal stem cells in fracture patients.
    Tan HB; Giannoudis PV; Boxall SA; McGonagle D; Jones E
    BMC Med; 2015 Jan; 13():6. PubMed ID: 25583409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.